Partner Judy Waltz and Senior Counsel Torrey Young were quoted in a Report on Medicare Compliance article, “Outlook 2020: Integrity Rule, Inpatient Audits Will Stir Things Up; Privacy is ‘Huge Focus,’” about compliance and enforcement issues that will be front and center this year.
Waltz said hospitals should prepare for enrollment changes because of a final 2019 CMS program-integrity regulation that could put their billing privileges in jeopardy. “It’s important for compliance officers right now to consider how the affiliation rules will impact them down the line,” she said.
Young said a proposed ESRD safe harbor provision would allow providers to give patients in-home dialysis telehealth technology if certain criteria are met. “It provides potential growth for ESRD, but the question is, if you have technology that doesn’t fit squarely within [the safe harbor], is their potential for enforcement?” she said.
People
Related News
25 July 2024
In the News
Donald Schroeder on Groff – ‘Supreme Court decision is inviting a more fact-based analysis’
Foley & Lardner LLP partner Donald Schroeder assessed the impact of the U.S. Supreme Court’s 2023 decision in a religious accommodation case as it returns to the district court in the Law360 article, “A Year After High Court Spotlight, Groff Case Still A Bellwether.”
24 July 2024
In the News
Louis Lehot Featured in Q&A on How Startups Can Prepare for IPO
Foley & Lardner LLP partner Louis Lehot features in the Q&A, "How startups can get in top shape for an IPO, according to Silicon Valley lawyer Louis Lehot," part of Business Insider's Road to IPO' series.
24 July 2024
In the News
Courtenay Brinckerhoff on Patent Cap in Drug Pricing – ‘Hard to predict if this will make a difference’
Foley & Lardner LLP partner Courtenay Brinckerhoff discussed a recent bill passed in the U.S. Senate aimed at lowering drug prices by limiting the number of patents that can be asserted in cases over biosimilars in the Law360 article, “Patent Cap In Drug Pricing Bill Seen As Having Muted Effect.”